is that going from dsm four to dsm-5? >> guest: a couple things. the dsm-5 so everyone is aware, that's watching, is the diagnostic statistics manual fifth edition for psychological and physical analysis or diagnoses, right? which is sort of similar to the pdr physicians desk reference, that an md would use. i'm going to shock the whole world now and people hate me for this but i'm going to say i don't think psychology is as much of the sites as it is an art. i'm not going to subscribe to that. >> guest: here you are a psychologist. >> guest: i love the state of personality. another study of the human being in the system, whether it's in you in congress for you in your family or your in society. i find the system for interesting and your development to the lifespan i also find very interesting. that's what i i studied most oy life. >> host: you are presuming i've had development along the way. [laughing] may be too much of a presumption. >> guest: but but i enjoy studg those things. i'm a researcher by nature. i was born just to devour information

julianna has been taking a close look at the report >> a strong report from dsm. they beat on total sales about 2% ahead of consensus. earnings were slightly ahead the portion that beat was down to this exceptional vitamin pricing, the benefit they had from that. the stock reacting quite well. up more than 2.5%. i want to just flag this, this is in the context of a 13% drop over the last six months a real recovery, a real relief bounce, particularly after we've seen some other chemical names like basf disappoint on earnings in the last few weeks. there's two things i want to highlight, one is the strength in vitamin pricing and two is the materials business on the vitamin pricing, we had a chance to catch up with the cfo this morning and ask about this exceptional pricing impact they're seeing which is estimated at 300 million euros for the year the key question is what we can expect for vitamin pricing moving forward let's listen in. >> we are continuing to see very good business conditions in our nutrition business across regions, and that applies to animal and

included in the dsm. also very large investments in the drugs that are used to treat it. psychological illnesses, to my understanding, are different than medical and assist. i believe you have to show a cause and effect. they'll have to be some proof out there that this is going to likely make the diabetes better. by and large, if i give you the drug, it's going to make it better. the other drugs on the other hand, don't have the proof. they don't have to prove, in fact in some cases, some of the drugs used today, have very little or any proof that they actually work on the disease they are being used for. >> there are some serious side effects. >> follow the money, there is some serious trust that needs to be uncovered. i'm raising five children and doing interviews on televisio television -- >> you worry about your kids. >> i worry about the future. here's the other thing, when you think take something, the second amendment, which is under fire all the time. i hear conservatives on a regular basis like,

i have no idea is that going from dsm-iv to dsm five? >> just so we are aware it is a diagnostic statistic manual for psychological analysis into diagnoses which is similar to the reference that an mde would use and i'm going to shock the whole world right now and people hate me for this come about i don't think psychology is as much of a science as it is an art and i'm not going to subscribe to that. i'm not a licensed psychologist and that's part of the reason i love the study of the personality and the human being in the system, whether it is you in congress were your family or society. i find the systems interesting and your developmenand/or devele lifespan i find in resting so that is what i studied most of my life. >> host: it may be too much of a presumption. >> guest: i am a researcher by name i was born to discover information and to try to make sense of human behavior. whatever one was out of the way i was able to get my hands on one that is how we had actual books we'd just go online and look at it but the point that i think i

and what the dsm-5 requires is some etiology, something that we can point to that helps us understand the maturation of this disease so that it's not early stage but late stage. and here, of course, you have two life-threatening strokes where he almost died and there were brain injuries. he now has cerebral vascular disease that we can see. so, under those circumstances -- and i -- i concede that there are going to be harder cases, there could be harder cases, but under these circumstances, the evidence is quite dramatic. there was no dispute that mr. madison suffers from severe vascular dementia using the criteria that the medical community has given to us about these kinds of diseases, which is why the state's concession that dementia could be a basis is so significant. what we wanted to prove to the judge below is that dementia, when it has these features, renders someone incompetent. and the perfect example comes from the record. mr. madison can explain to you that he has a toilet in his cell. it's a 5-by-8 cell. he can explain to you that he can use that toilet. but he routinely

with networks based on the dsm a standard and what networks that were based on the cdma standard. alternately it was good to see those technologies can be because each of those technologies drove the other want to be more efficient, to be faster and to innovate faster. if we had the same thing happen here i hope we get the same result, that we see engineers fighting to make the standard better, d.c. engineers pushing the boundaries of what wireless can do. having to make standards compete isn't the best thing for economies of scale but sometimes they can produce some amazing results. >> host: is 5g available in were in the states and when to use a rollup? >> guest: 5g is tough to define and century of figured it up. 5g is a catchall term to address a a number of new technologies. verizon and at&t have both made investments about deployment this year. 5g though, the new radios that we hear about, the new technology is further down the road. it's not out there in the marketplace yet but those of the advances that once these new pieces of equipment are put in place and can be upgrade

coming through from santander, airbus, dsm, air france klm, the list goes on lots of individual corporateooking for moves higher from the likes of l'oreal as well. profits were down for air france klm, but came in above estimates. inx up by 1.2%. the corporate story being factored in, up by 1.4%. but see what matt miller sees.

coming through from santander, airbus, dsm, air france klm, the list goes on lots of individual corporate stories. we are looking for moves higher from the likes of l'oreal as well. profits were down for air france klm, but came in above estimates. inx up by 1.2%. the corporate story being factored in, up by 1.4%. but see what matt miller sees. matt: let me give you the spanish gdp growth. you're talking about that. we do see spain's quarter gdp rising. the estimate was for 2.5%, so bank . helpful to should be the european numbers, although france yesterday was hurtful. here, you can see the euro-dollar trading, though not much has changed. the imap is concerned, he saw green across pretty much all of the industrial sectors. as anna said, more treat them trick today. although this month has been a hell of a trick for equity investors who are along these markets. consumer discretionary stocks are not holding up as well, health care either. but there have been individual earnings stories that could move separate from the rest. what do you see in the mrr? anna: let's have a look at those, we